The cell proliferation antigen Ki-67 organises heterochromatin.
Michal SobeckiKarim MroujAlain CamassesNikolaos ParisisEmilien NicolasDavid LlèresFrançois GerbeSusana PrietoLiliana KrasinskaAlexandre DavidManuel EgurenMarie-Christine BirlingSerge UrbachSonia HemJérôme DéjardinMarcos MalumbresPhilippe JayVjekoslav DulicDenis Lj LafontaineRobert FeilDaniel FisherPublished in: eLife (2016)
Antigen Ki-67 is a nuclear protein expressed in proliferating mammalian cells. It is widely used in cancer histopathology but its functions remain unclear. Here, we show that Ki-67 controls heterochromatin organisation. Altering Ki-67 expression levels did not significantly affect cell proliferation in vivo. Ki-67 mutant mice developed normally and cells lacking Ki-67 proliferated efficiently. Conversely, upregulation of Ki-67 expression in differentiated tissues did not prevent cell cycle arrest. Ki-67 interactors included proteins involved in nucleolar processes and chromatin regulators. Ki-67 depletion disrupted nucleologenesis but did not inhibit pre-rRNA processing. In contrast, it altered gene expression. Ki-67 silencing also had wide-ranging effects on chromatin organisation, disrupting heterochromatin compaction and long-range genomic interactions. Trimethylation of histone H3K9 and H4K20 was relocalised within the nucleus. Finally, overexpression of human or Xenopus Ki-67 induced ectopic heterochromatin formation. Altogether, our results suggest that Ki-67 expression in proliferating cells spatially organises heterochromatin, thereby controlling gene expression.
Keyphrases
- gene expression
- neoadjuvant chemotherapy
- cell proliferation
- cell cycle arrest
- poor prognosis
- dna methylation
- transcription factor
- pi k akt
- cell death
- magnetic resonance imaging
- signaling pathway
- locally advanced
- metabolic syndrome
- endothelial cells
- squamous cell carcinoma
- radiation therapy
- binding protein
- lymph node
- computed tomography
- small molecule
- rectal cancer
- functional connectivity